Prospective study of embolization of thoracic wall artery for tumors of thoracic wall and pleura

Prospective study of embolization of thoracic wall artery for tumors of thoracic wall and pleura - Prospective study of embolization of thoracic wall artery for thoracic wall tumors

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022409

Enrollment

100

Registered

2016-05-23

Start date

2016-05-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant tumors of thoracic wall and pleura

Interventions

NBCA is used during the embolization in less than 10ml.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Malignant tumors of thoraci wall and pleura which can be hardly treated by surgery, radiation therapy, and chemotherapy. 2. Resectable tumors, which had better to be shrinked before surgery.

Exclusion criteria

Exclusion criteria: 1

Design outcomes

Primary

Measure	Time frame
1. Adverse event within one week of treatment 2. Antitumor effect within 3 months	—

Secondary

Measure	Time frame
1. Tumor shrinking period within 1 year 2. Local recurrence rate within 1 year 3. Prognosis in 3 years	—

Countries

Japan

Contacts

Public ContactHiroaki Nomori, MD

Kameda Medical Center Thoracic Surgery

hnomori@qk9.so-net.ne.jp0470-92-2211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026